Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus J Zervos

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Diagnostic Microbiology and Infectious Disease|May 15, 2002
In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycinMary Beth Perri, Ellie Hershberger, Mihaela Ionescu, et al.
Clinical Microbiology Reviews|April 1, 2016
Pertussis: Microbiology, Disease, Treatment, and PreventionPaul E Kilgore, Abdulbaset M Salim, Marcus J Zervos, et al.
Infectious Diseases and Therapy|March 8, 2017
The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsLauren K Flynt, Rachel M Kenney, Marcus J Zervos, et al.
Expert Opinion on Pharmacotherapy|June 8, 2018
Combatting resistant enterococcal infections: a pharmacotherapy reviewNicholas J Mercuro, Susan L Davis, Marcus J Zervos, et al.
Infection|June 2, 2016
False-positive cerebrospinal fluid cryptococcus antigen in Libman-Sacks endocarditisIyad N Isseh, Kassem Bourgi, Asaad Nakhle, et al.
Clinical Microbiology Reviews|July 19, 2006
Application of molecular techniques to the study of hospital infectionAparajita Singh, Richard V Goering, Shabbir Simjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2008
Dalbavancin: a novel once-weekly lipoglycopeptide antibioticMarianne Billeter, Marcus J Zervos, Anne Y Chen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 30, 2017
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes studySamia Arshad, Vanthida Huang, Pamela Hartman, et al.
Diagnostic Microbiology and Infectious Disease|August 30, 2020
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureusMary A Hutton, Ayesha Sundaram, Mary B Perri, et al.
International Journal of Antimicrobial Agents|April 2, 2023
Aminopenicillins vs non-aminopenicillins for treatment of enterococcal lower urinary tract infectionsJamison E Montes de Oca, Michael P Veve, Marcus J Zervos, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Diagnostic Microbiology and Infectious Disease|May 15, 2002
In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycinMary Beth Perri, Ellie Hershberger, Mihaela Ionescu, et al.
Clinical Microbiology Reviews|April 1, 2016
Pertussis: Microbiology, Disease, Treatment, and PreventionPaul E Kilgore, Abdulbaset M Salim, Marcus J Zervos, et al.
Infectious Diseases and Therapy|March 8, 2017
The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsLauren K Flynt, Rachel M Kenney, Marcus J Zervos, et al.
Expert Opinion on Pharmacotherapy|June 8, 2018
Combatting resistant enterococcal infections: a pharmacotherapy reviewNicholas J Mercuro, Susan L Davis, Marcus J Zervos, et al.
Infection|June 2, 2016
False-positive cerebrospinal fluid cryptococcus antigen in Libman-Sacks endocarditisIyad N Isseh, Kassem Bourgi, Asaad Nakhle, et al.
Clinical Microbiology Reviews|July 19, 2006
Application of molecular techniques to the study of hospital infectionAparajita Singh, Richard V Goering, Shabbir Simjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2008
Dalbavancin: a novel once-weekly lipoglycopeptide antibioticMarianne Billeter, Marcus J Zervos, Anne Y Chen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 30, 2017
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes studySamia Arshad, Vanthida Huang, Pamela Hartman, et al.
Diagnostic Microbiology and Infectious Disease|August 30, 2020
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureusMary A Hutton, Ayesha Sundaram, Mary B Perri, et al.
International Journal of Antimicrobial Agents|April 2, 2023
Aminopenicillins vs non-aminopenicillins for treatment of enterococcal lower urinary tract infectionsJamison E Montes de Oca, Michael P Veve, Marcus J Zervos, et al.
Pageof 9